scispace - formally typeset
A

Alicia Cronquist

Researcher at Colorado Department of Public Health and Environment

Publications -  43
Citations -  4393

Alicia Cronquist is an academic researcher from Colorado Department of Public Health and Environment. The author has contributed to research in topics: Population & Outbreak. The author has an hindex of 28, co-authored 41 publications receiving 3776 citations.

Papers
More filters
Journal Article

Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food - 10 states, 2008.

TL;DR: In 2008, the estimated incidence of infections caused by Campylobacter, Cryptosporidium, Cyclospora, Listeria, Shiga toxin-producing Escherichia coli O157, Salmonella, Shigella, Vibrio, and Yersinia did not change significantly when compared with the preceding 3 years.
Journal ArticleDOI

Salmonellosis Outcomes Differ Substantially by Serotype

TL;DR: Salmonella serotypes are closely related genetically yet differ significantly in their pathogenic potentials, and understanding the mechanisms responsible for this may be key to a more general understanding of the invasiveness of intestinal bacterial infections.
Journal ArticleDOI

Increased recognition of non-O157 Shiga toxin-producing Escherichia coli infections in the United States during 2000-2010: epidemiologic features and comparison with E. coli O157 infections.

TL;DR: To detect both O157 and non-O157 STEC infections, clinical laboratories should routinely and simultaneously test all stool specimens submitted for diagnosis of acute community-acquired diarrhea for O157STEC and for Shiga toxin and ensure that isolates are sent to a public health laboratory for serotyping and subtyping.
Journal ArticleDOI

COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021

TL;DR: The highest impact of booster doses against infection and death compared with full vaccination without booster doses was recorded among persons aged 50-64 and ≥65 years, and eligibility to stay up to date with COVID-19 vaccinations.